Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest announcement is out from AddLife AB ( ($SE:ALIF.B) ).
AddLife AB has published its 2025 Annual Report, providing a comprehensive overview of its operations, strategy, governance, financial performance, and sustainability work. The report covers the company’s market environment, acquisition activity, long-term financial targets, and the development of its Labtech and Medtech business areas, offering stakeholders detailed insight into how AddLife is positioning itself for continued growth and value creation.
The document also presents the Administration Report, Corporate Governance report, and extensive sustainability disclosures, including environmental, social, and governance information. Together with multi-year overviews, definitions, and the auditor’s report, the publication is intended to enhance transparency for investors and other stakeholders and to clarify how the company manages risks, capital allocation, and responsible business practices over time.
The most recent analyst rating on ($SE:ALIF.B) stock is a Hold with a SEK145.00 price target. To see the full list of analyst forecasts on AddLife AB stock, see the SE:ALIF.B Stock Forecast page.
More about AddLife AB
AddLife AB is a life science company operating in the lab technology and medical technology sectors. Through its Labtech and Medtech business areas, it supplies products and solutions that aim to improve people’s lives, serving healthcare, laboratory, and related markets with a portfolio that combines equipment, services, and specialized expertise.
Average Trading Volume: 171,437
Technical Sentiment Signal: Sell
Current Market Cap: SEK17.01B
See more insights into ALIF.B stock on TipRanks’ Stock Analysis page.